
Hanyu Pharmaceutical | The fifth batch of national drug centralized purchase selected from the "thymic method for injection"
- Categories:未分类
- Author:
- Origin:
- Time of issue:2021-06-24 17:16
- Views:
(Summary description)This time, 62 drugs were included in the centralized purchase of drugs organized by the state, and the purchase amount of the provincial platform reached 55 billion yuan in 2020, setting a new record for centralized purchase. From the perspective of purchased drug dosage forms, the quantity of injections accounts for half, and the amount involved accounts for 70%, making them the main dosage forms of this centralized purchase. On the morning of June 23, the fifth batch of centralized procurement of national drugs organized by the State Health Insurance Administration and other relevant departments opened in Shanghai, with more than 200 pharmaceutical enterprises including Hanyu Pharmaceutical. The company's key product thymosin for injection was successfully selected at an excellent price. Not long ago, the product had just passed the consistency evaluation. This is another major product of Hanyu Pharmaceutical successfully won the bid after the second batch of national centralized purchase of trimetazidine hydrochloride sustained-release tablets. According to market statistics, the sales of this product will be nearly 1.1 billion yuan in 2020. This selection will help the company expand its market share, expand its market share and improve its core competitiveness.
Hanyu Pharmaceutical | The fifth batch of national drug centralized purchase selected from the "thymic method for injection"
(Summary description)This time, 62 drugs were included in the centralized purchase of drugs organized by the state, and the purchase amount of the provincial platform reached 55 billion yuan in 2020, setting a new record for centralized purchase. From the perspective of purchased drug dosage forms, the quantity of injections accounts for half, and the amount involved accounts for 70%, making them the main dosage forms of this centralized purchase. On the morning of June 23, the fifth batch of centralized procurement of national drugs organized by the State Health Insurance Administration and other relevant departments opened in Shanghai, with more than 200 pharmaceutical enterprises including Hanyu Pharmaceutical. The company's key product thymosin for injection was successfully selected at an excellent price. Not long ago, the product had just passed the consistency evaluation. This is another major product of Hanyu Pharmaceutical successfully won the bid after the second batch of national centralized purchase of trimetazidine hydrochloride sustained-release tablets. According to market statistics, the sales of this product will be nearly 1.1 billion yuan in 2020. This selection will help the company expand its market share, expand its market share and improve its core competitiveness.
- Categories:未分类
- Author:
- Origin:
- Time of issue:2021-06-24 17:16
- Views:
On the morning of June 23, the fifth batch of centralized procurement of national drugs organized by the State Health Insurance Administration and other relevant departments opened in Shanghai, with more than 200 pharmaceutical enterprises including Hanyu Pharmaceutical. The company's key product thymosin for injection was successfully selected at an excellent price. Not long ago, the product had just passed the consistency evaluation. This is another major product of Hanyu Pharmaceutical successfully won the bid after the second batch of national centralized purchase of trimetazidine hydrochloride sustained-release tablets. According to market statistics, the sales of this product will be nearly 1.1 billion yuan in 2020. This selection will help the company expand its market share, expand its market share and improve its core competitiveness.
Thymosin is a chemically synthesized polypeptide immunomodulator composed of 28 amino acids. Clinically, it is mainly used for auxiliary treatment of patients with chronic hepatitis B, chronic viral infection, tumor and immune deficiency, which can enhance the body's anti-virus, anti-bacterial and anti-tumor immune response. During the COVID-19 in 2020, Hanyu Pharmaceutical's thymus injection method was widely used in the frontline of anti epidemic, to improve the antiviral immunity of front-line medical personnel, and was listed as a prevention and control drug by medical and health departments in many places.
According to the provisions of the national drug centralized procurement document issued by Joint Procurement, if the number of enterprises selected in the country is 4 or more, the agreed procurement volume in the first year of each region is 80% of the calculation base of the agreed procurement volume in the first year, and the procurement cycle is 3 years in principle.
This time, 62 drugs were included in the centralized purchase of drugs organized by the state, and the purchase amount of the provincial platform reached 55 billion yuan in 2020, setting a new record for centralized purchase. From the perspective of purchased drug dosage forms, the quantity of injections accounts for half, and the amount involved accounts for 70%, making them the main dosage forms of this centralized purchase.
SERVICE HOTLINE
(020)8981 0500
HOME | ABOUT | INVESTMENT | NEWS | CONTACT
Copyright◎2024 INFINITE CAPITAL HOLDING COMPANY
